General discussion, page-20036

Some of the negativity in here is incredible.

Understandably anyone who's been a long-term holder of Inncanex is down a lot of money and we're all feeling frustrated and upset at both the price action and the lack of payoff from the move to the US. But the overall goal of Joel and the board would still well and truly be a share price multiples of where we are now. $600k yearly wage is good money for our CEO, but getting our share price back to ATH's of 75c when you hold 23,000,000 shares (Aus equivalent) is much better motivation to work hard than a $600,000 salary.

We all knew this would be a long grind and I'm as confused and shocked by the low share price as anyone but we operate in a biotech speculative space. Use Botanic Pharmaceuticals for example, they got as low as 2.5c Aus a few years ago having dropped from 27c and now years later they are sitting at 38c and have just raised $70 million. I've followed that company for just as long as this one and the forums mirror each other with holders back then tearing at each others throats and calling for the boards head when they had bottomed up. The conversations now they are sitting at a $600 million market cap are very very different now and mind you they've had the same management the whole time. We've got a much better product pipeline, I would argue better managers who are more globally recognized and our market potential is multiples of theirs.

If we hit our milestones later this year from good OSA results, there's absolutely no way we sit at this level for long. I'm still holding and have plenty of faith that my patience will be rewarded.

As Warren Buffet says, 'Our favorite holding time is forever' & 'The Stock Market is a device for transferring money from the impatient to the patient'.

Goodluck to all holders.